114 related articles for article (PubMed ID: 2348481)
21. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ
Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860
[TBL] [Abstract][Full Text] [Related]
22. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations.
Chang GJ; Su MJ; Kuo SC; Lin TP; Lee YS
J Pharmacol Exp Ther; 2006 Jan; 316(1):380-91. PubMed ID: 16174797
[TBL] [Abstract][Full Text] [Related]
23. [Effects of methylflavonolamine hydrochloride on physiologic properties of isolated guinea pig atrium].
Guo SR; Zhou EF
Yao Xue Xue Bao; 1989; 24(7):543-5. PubMed ID: 2618697
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of berberine on IK1, IK, and HERG channels of cardiac myocytes.
Li BX; Yang BF; Zhou J; Xu CQ; Li YR
Acta Pharmacol Sin; 2001 Feb; 22(2):125-31. PubMed ID: 11741516
[TBL] [Abstract][Full Text] [Related]
25. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 1st communication: phosphodiesterase III inhibitory effect and class III antiarrhythmic effect in guinea-pig heart.
Hino M; Sugawara H; Yoshimura A; Ogura A; Yoshioka K; Sakato M; Endoh M
Arzneimittelforschung; 1999 May; 49(5):398-406. PubMed ID: 10367101
[TBL] [Abstract][Full Text] [Related]
26. Effect of rhyncophylline on potassium channels in isolated rat or guinea pig ventricular myocytes.
Wang XL; Zhang LM; Hua Z
Yao Xue Xue Bao; 1994; 29(1):9-14. PubMed ID: 8036902
[TBL] [Abstract][Full Text] [Related]
27. Rate-dependent class III antiarrhythmic action, negative chronotropy, and positive inotropy of a novel Ik blocking drug, UK-68,798: potent in guinea pig but no effect in rat myocardium.
Tande PM; Bjørnstad H; Yang T; Refsum H
J Cardiovasc Pharmacol; 1990 Sep; 16(3):401-10. PubMed ID: 1700210
[TBL] [Abstract][Full Text] [Related]
28. Electrophysiological basis for the antiarrhythmic action and positive inotropy of HA-7, a furoquinoline alkaloid derivative, in rat heart.
Su MJ; Chang GJ; Wu MH; Kuo SC
Br J Pharmacol; 1997 Dec; 122(7):1285-98. PubMed ID: 9421274
[TBL] [Abstract][Full Text] [Related]
29. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
[TBL] [Abstract][Full Text] [Related]
30. [Effects of benzyltetrahydropalmatine on alpha, beta and other receptors].
Zhang JS; Huang ZY; Yao WX; Xia GJ; Jiang MX
Yao Xue Xue Bao; 1988; 23(9):641-5. PubMed ID: 2855684
[No Abstract] [Full Text] [Related]
31. [Antiarrhythmic effect of TJ0711].
Zhang XJ; Qiu J; Li G
Yao Xue Xue Bao; 2014 Mar; 49(3):419-26. PubMed ID: 24961117
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological activity of (-)-discretamine, a novel vascular alpha-adrenoceptor and 5-hydroxytryptamine receptor antagonist, isolated from Fissistigma glaucescens.
Ko FN; Yu SM; Su MJ; Wu YC; Teng CM
Br J Pharmacol; 1993 Oct; 110(2):882-8. PubMed ID: 7902181
[TBL] [Abstract][Full Text] [Related]
33. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization.
Carlsson L; Abrahamsson C; Drews L; Duker G
Circulation; 1992 Apr; 85(4):1491-500. PubMed ID: 1555289
[TBL] [Abstract][Full Text] [Related]
34. In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C: electrophysiological, anti-adrenergic, and anti-angiotensin II effects.
Gautier P; Guillemare E; Djandjighian L; Marion A; Planchenault J; Bernhart C; Herbert JM; Nisato D
J Cardiovasc Pharmacol; 2004 Aug; 44(2):244-57. PubMed ID: 15243307
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of 1-(2, 6-dimethylphenoxy)-2-(3, 4-dimethoxyphenyl-ethylamino) propane hydrochloride on inward rectifier and delayed rectifier K+ currents in guinea pig ventricular myocytes.
Zhong N; Fang QZ; Zhang Y; Qian JQ; Zhou ZN
Acta Pharmacol Sin; 2000 Apr; 21(4):301-5. PubMed ID: 11324454
[TBL] [Abstract][Full Text] [Related]
36. The new antiarrhythmic substance AWD 23-111 inhibits the delayed rectifier potassium current (IK) in guinea pig ventricular myocytes.
Klapperstück M; Markwardt F
Pharmazie; 1999 Jan; 54(1):61-8. PubMed ID: 9987799
[TBL] [Abstract][Full Text] [Related]
37. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
[TBL] [Abstract][Full Text] [Related]
38. Specific IK1 blockade: a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate.
Rees SA; Curtis MJ
Circulation; 1993 Jun; 87(6):1979-89. PubMed ID: 8504513
[TBL] [Abstract][Full Text] [Related]
39. [Anti-arrhythmic mechanisms of sophoramine].
Yao JA; Zhang BH
Zhongguo Yao Li Xue Bao; 1989 Jul; 10(4):315-9. PubMed ID: 2624114
[TBL] [Abstract][Full Text] [Related]
40. Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat.
Pugsley MK; Saint DA; Hayes ES; Kramer D; Walker MJ
J Cardiovasc Pharmacol; 1998 Dec; 32(6):863-74. PubMed ID: 9869491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
